related documents
- A psychoeducation trial for people with chronic stable angina Conferences
- Baseline plasma NT-proBNP concentrations in relation to clinical characteristics: Results from the irbesartan in heart failure with preserved systolic function trial Conferences
- Cardiac structural changes and diastolic function in heart failure with preserved ejection fraction - Importance of left atrial volume: the iPRESERVE study Conferences
- Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) Study Conferences
- Effect of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic chronic heart failure and iron deficiency: A randomised, controlled, observer-blinded trial (FERRIC-HF) Conferences
- Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment Conferences
- Endothelial anticoagulant heparan sulfate mediates anti-inflammatory effects of antithrombin in sepsis. Conferences
- Endothelin-1 antagonism and nitric oxide augmentation prevents CyA induced vasomotor impairment Conferences
- Fasting plasma glucose is an independent predictor of hospitalization for congestive heart failure in high-risk patients Conferences
- Fondaparinux versus control (placebo or unfractionated heparin) as an adjunct to thrombolytic therapy in acute myocardial infarction: an OASIS 6 substudy Conferences
- Guideline adherent antithrombotic treatment is associated with improved cardiovascular outcome compared to undertreatment in real-life atrial fibrillation patients at high risk for stroke Conferences
- High heritabilities of serum metabolites and differential metabolomic profiles in families burdened with early onset coronary artery disease Conferences
- Impact of vascular events on mortality in AF patients: Insights from ACTIVE W Conferences
- Incidence of heparin-induced thrombocytopenia lower than expected patients with acute coronary syndromes. The global registry of acute coronary events Conferences
- Increase in risk of death in early months following hospitalization for heart failure: Observations from the CHARM program Conferences
- Lack of interaction between angiotensin receptor blocker and aspirin in patients with heart failure Conferences
- Long term effects of ultrasound-mediated VEGF165 delivery on microvascular perfusion and endogenous growth factor expression chronic ischemia Conferences
- Long-term adherence to the ACC/AHA class I post-discharge medications and recommendations using optimal medical therapy in 2,287 patients with established coronary heart disease: Interim data from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial Conferences
- Major bleeding in patients with acute coronary syndrome undergoing early invasive management can be reduced by fondaparinux, even in the context of trans-radial coronary intervention: Insights from OASIS-5 trial Conferences
- Neither ramipril nor vitamin E reduces the incidence of atrial fibrillation. Results of the HOPE study. Conferences
- Noninvasive measures of subclinical atherosclerosis in children, a systematic overview Conferences
- Should we abandon the paradigm of withholding oral anticoagulation in paroxysmal atrial fibrillation? Conferences